Names of countries given after Members' names are in accordance with the ZUPAC Handbook 1991-93; changes will be effected in the 1994-95 edition.
Applications of I U PAC-I FCC recommendations on quantities and units to WHO biological reference materials for diagnostic use
This document deals with the nature of WHO biological reference materials, their development for the control of therapeutic substances and recommendations to improve their application in diagnosis. The nature of international units specified by WHO biological reference materials is contrasted with that of SI units, and the method for assigning values in international units to such reference materials is described. The document recommends the use of SI units (mole) with existing and proposed WHO biological reference materials whenever the elementary entity of the stated component can be recognized. It also recommends that the description of quantities having no recognized kind-of-quantity with a definable dimension should be clearly distinguished by the term "arbitrary" and include a reference to Over this latter period, the IFCC and W A C have adopted and developed a comprehensive and coherent system of quantities and units for use in laboratory medicine (Ref. 5.3). This system, which is based on a sound theoretical framework shared with other physical and chemical sciences, has resulted in the worldwide introduction of the International System of Units (SI) into laboratory medicine.
Introduction
Workers in clinical laboratory sciences have therefore become increasingly conversant with SI and with IUPAC/IFCC recommendations on quantities and units. However, difficulties arise in the use of the quantities and international units specified for some WHO biological reference materials. This is largely because these quantities and units are not readily reconciled with those of the WAC-IFCC recommendations. There is also often a lack of understanding about the relevant WHO standard to be used and the mode of expression of results. These difficulties lead to the incorrect use of biological standards in clinical laboratory sciences resulting in the presentation of erroneous or insufficient data.
Through the initiatives of the IFCC Committee on Quantities and Units and the W A C Commission on Quantities and Units in Clinical Chemistry and following consultations with representatives of WHO, a
Consulting Working Group was set up to consider these issues. This Group met at WHO (Geneva) in January 1991 and October 1992.
The statements and recommendations below were agreed, based upon references 5.3,5.4 and 5.5.
Quantities and units
A quantity measured in the clinical laboratory must be described in terms of the following elements and structure (Ref.
5.3).
Elements and structure The magnitude of the quantity is expressed by the product of numerical value and unit. Thus, quantity = numerical value. unit
The concept of quantity applies more particularly to that property of a reference material that is assigned a value. W h e~ applicable, the unit should be of the International System of Units (SI). When a reference material is made for the first time and cannot be characterized by a kind-of-quantity used with the SI, its assigned value (in terms of an international unit) is arbitrary. Replacement preparations are assigned values based on that of the preceding preparation.
When "procedureinternational units have to be used, it may be necessary to assign the value on the basis of only one reference measurement procedure utilized by all laboratories participating in the collaborative trial. In changing into a kind-of-quantity of well known dimension and an SI unit, there is metrological strength in employing different methods and even principles of measurement.
Recommendations
In the field of laboratory medicine, the use of an international unit in measured values of a quantity is a way of circumventing the problem of having a component (analyte) that does not have a known elementary entity.
when an elementary entity for the stated component can be recognized, a kind-of-quantity based on amountof-substance (unit: mole) is preferred, e.g. for a given polypeptide.
The i n f d o n relating to each existing and proposed WHO reference material should be examined to see whether knowledge about the system and component(s) would allow defining a kind-of-quantity based on amount-of-substance (unit: mole) and assigning a value with an SI unit.
For quantities having no recogtllzed kind-ofquantity with a definable dimension, the term "arbitrary" should precede the usual kind-of-quantity name and a reference to the "procedure" and to the calibrator should follow the kind-of-quantity in the systematic name. Thus kind-of-quantities of an arbitrary nature always need specifications. Example: For concentration of lutropin, the kind-of-quantity could be "arbitrary substance concentration(immun0procedure X, IS 80/552)".
Guidelines for the use of a reference material should state the procedure(s) for which the material has been found suitable. WHO is urged to form a group involving appropriate non-governmental organizations to advise on the need for international reference materials for clinical laboratory investigations and to review and advise on documentaton submitied to the Expert Canmittee on Biological Standardization in support of certification.
WHO is urged to continue and to expand its programme for the production of international reference materials suitable for clinical diagnosis (Ref. 5.8) .
